Charles River Laboratories International

The drug research and development process is highly complex, lengthy and expensive, yet essential for delivering safe and effective therapies to patients. To help our clients navigate this process, Charles River offers a wide range of products and services that span the entire drug discovery and development continuum and can be tailored to specific research conditions.

Company Growth (employees)
Wilmington, US
Size (employees)
11,000 (est)+28%
Charles River Laboratories International was founded in 1947 and is headquartered in Wilmington, US

Charles River Laboratories International Office Locations

Charles River Laboratories International has an office in Wilmington
Wilmington, US (HQ)
251 Ballardvale Street

Charles River Laboratories International Data and Metrics

Charles River Laboratories International Financial Metrics

Charles River Laboratories International's revenue was reported to be $1.7 b in FY, 2016 which is a 23% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

1.7 b

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

1.4 b

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

156.4 m

EBIT (FY, 2016)

237.4 m

Market capitalization (25-May-2017)

4.4 b

Closing share price (25-May-2017)


Cash (31-Dec-2016)

117.6 m
Charles River Laboratories International's current market capitalization is $4.4 b.
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016


1.2 b1.3 b1.4 b1.7 b

Revenue growth, %


Cost of goods sold

264 m277 m

Gross profit

671.4 m739.1 m1.1 b1.4 b

Gross profit Margin, %



151.4 m177.7 m206.4 m237.4 m

EBIT margin, %


Interest income

1 m1.3 m

Net Income

104.2 m128.4 m151.1 m156.4 m
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016


155.9 m160 m117.9 m117.6 m

Accounts Receivable

220.6 m258 m270.1 m364.1 m


89.4 m89 m93.7 m95.8 m

Current Assets

552.6 m606.9 m559.2 m656.8 m


676.2 m676.8 m678 m755.8 m


230.7 m321.1 m438.8 m787.5 m

Total Assets

1.6 b1.9 b2.1 b2.7 b

Accounts Payable

31.8 m33.8 m36.7 m68.5 m

Current Liabilities

247 m296.2 m311.8 m429.6 m

Additional Paid-in Capital

2.2 b2.3 b2.4 b2.5 b

Retained Earnings

(265.5 m)(138.8 m)10.5 m165.3 m

Total Equity

664.7 m737.6 m839.1 m

Financial Leverage

2.5 x2.8 x3.2 x
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

104.2 m128.2 m151.1 m156.4 m

Depreciation and Amortization

96.6 m96.4 m24.2 m41.7 m

Accounts Receivable

(17 m)(53 m)


(1.6 m)(3 m)3.4 m(4 m)

Accounts Payable

(7.1 m)4.6 m1.2 m22.1 m

Cash From Operating Activities

209 m252.1 m288.2 m300.4 m

Capital Expenditures

39.2 m(56.9 m)(63.3 m)(55.3 m)

Cash From Investing Activities

(74 m)(298 m)(320.3 m)(686.4 m)

Cash From Financing Activities

(84.2 m)61.4 m4.5 m390.7 m

Interest Paid

12 m10.2 m11.1 m22.8 m

Income Taxes Paid

19.1 m29.7 m24.4 m42.9 m

Free Cash Flow

169.9 m309.1 m351.5 m355.7 m
Numbers are in $, USDY, 2016


195.5 k

Financial Leverage

3.2 x

Charles River Laboratories International Market Value History

Charles River Laboratories International Online and Social Media Presence

Charles River Laboratories International News and Updates

Charles River Laboratories International Company Life and Culture

You may also be interested in